Inventor · disambiguated record
Elaine Phillips
Also filed as: PHILLIPS ELAINE · PHILLIPS ELAINE M
10 granted patents·14 pending applications·66 citations·filing 2007–2023
88Inventor score
Files withUNIV CALIFORNIA7MERITAGE PHARMA INC5VIROPHARMA BIOLOGICS LLC4PHILLIPS ELAINE3VERUS PHARMACEUTICALS INC2
Top patents by PatentIndex Score
24 records- 0196US10272037B2Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tractUNIV CALIFORNIA·Filed 2017·Granted Apr 30, 2019·13 cites·17 claims
- 0295US9782347B2Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tractUNIV CALIFORNIA·Filed 2014·Granted Oct 10, 2017·14 cites·20 claims
- 0394US8497258B2Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tractDOHIL RANJAN·Filed 2008·Granted Jul 30, 2013·15 cites·13 claims
- 0493US9119863B2Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tractUNIV CALIFORNIA·Filed 2013·Granted Sep 1, 2015·8 cites·22 claims
- 0582US9050368B2Corticosteroid compositionsPHILLIPS ELAINE·Filed 2008·Granted Jun 9, 2015·9 cites·48 claims
- 0681US8865692B2Compositions for the treatment of gastrointestinal inflammationPHILLIPS ELAINE·Filed 2008·Granted Oct 21, 2014·6 cites·1 claims
- 0781US2024108730A1Corticosteroid compositionsVIROPHARMA BIOLOGICS LLC·Filed 2023·Application pending·0 cites
- 0878US11413296B2Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tractUNIV CALIFORNIA·Filed 2015·Granted Aug 16, 2022·1 cites·15 claims
- 0978US2023255984A1Corticosteroid compositionsVIROPHARMA BIOLOGICS LLC·Filed 2023·Application pending·0 cites
- 1077US2022323463A1Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tractUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1177US2022331242A1Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tractUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 1275US11197822B2Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tractUNIV CALIFORNIA·Filed 2019·Granted Dec 14, 2021·0 cites·24 claims
- 1372US11357859B2Compositions for the treatment of gastrointestinal inflammationVIROPHARMA BIOLOGICS LLC·Filed 2019·Granted Jun 14, 2022·0 cites·11 claims
- 1462US10293052B2Compositions for the treatment of gastrointestinal inflammationMERITAGE PHARMA INC·Filed 2014·Granted May 21, 2019·0 cites·12 claims
- 1562US2009149433A1Compositions for the treatment of inflammation of the gastrointestinal tractMERITAGE PHARMA INC·Filed 2008·Application pending·0 cites
- 1662US2008020003A1Methods for the delivery of a beta2 agonist to induce bronchodilation and formulations for use in the sameVERUS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1758US2022273801A1Compositions for the treatment of gastrointestinal inflammationVIROPHARMA BIOLOGICS LLC·Filed 2022·Application pending·0 cites
- 1851US2007276048A1Unit dose formulations comprising an inhalable solution of albuterolVERUS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1947US2009123551A1Gastrointestinal delivery systemsMERITAGE PHARMA INC·Filed 2008·Application pending·0 cites
- 2046US2018043585A9Delivery of particles using hygroscopic excipientsUNIV VIRGINIA COMMONWEALTH·Filed 2014·Application pending·0 cites
- 2143US2007203247A1Epinephrine dosing regimensPHILLIPS ELAINE·Filed 2007·Application pending·0 cites
- 2236US2015231156A1Corticosteroid compositionsMERITAGE PHARMA INC·Filed 2015·Application pending·0 cites
- 2333US2011097401A1Methods for treating gastrointestinal disordersMERITAGE PHARMA INC·Filed 2010·Application pending·0 cites
- 2432US2012164080A1Methods of treatment for esophageal inflammationHILL MALCOLM·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elaine Phillips files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →